brand logo

Am Fam Physician. 2024;109(2):175-176

Author disclosure: No relevant financial relationships.

Lipoprotein(a)Refine ASCVD riskAdults at risk of ASCVD$39 to $177

Lipoprotein(a), or Lp(a), is a genetically determined low-density lipoprotein (LDL) subtype, which has been identified as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD).13 The Lp(a) test is approved by the U.S. Food and Drug Administration; however, there are no universally accepted screening indications. The American College of Cardiology/American Heart Association (ACC/AHA) recommends screening for adults who have a family or personal history of premature ASCVD.4 The ACC/AHA further considers Lp(a) levels greater than 50 mg per dL (125 nmol per L) to be risk-enhancing for ASCVD.112

Already a member/subscriber?  Log In


From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available

Issue Access

  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

This series is coordinated by Natasha Pyzocha, DO, contributing editor.

A collection of Diagnostic Tests published in AFP is available at

Continue Reading

More in AFP

More in PubMed

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.